INTRODUCTION
HIV (human immunodeficiency viru the subsequent development of the assoc know as AIDS (acquired immunodefici remains an ongoing disease of pandemic p its identification in the early 1980s. Yet modern molecular and cellular instrum diagnostics of the infection, as well as avail active] anti-retroviral therapy ([HA]ART) h infection to low penetrance in countri technologies and interventions are re However, epidemiological statistics show t income countries consistently maintain the of HIV ( Fig. 1) , with Sub-Saharan Africa heavily affected (69% of the 34 million 2011) [1] . Access to rapid and reliable di regions is low due to limited infrastruc technical know-how. Alternatives to the standard" are currently investigated to diagnostics to be deployed in such regions. Care" (PoC) devices aim to be capable remote villages with minimal power and can then be immediately delivered to a pati positive for HIV in these areas.
The target of the HIV virus is the T-h patient. Progressive loss of these cells suppression of the immune system and t AIDS. T-helper cells have a specific protei cell surface called CD4, and hence CD4 c key clinical determinant for diagnosis of H the initiation of treatment. While healthy in a CD4 cell count of > 1200 cells μl -1 i common practice is that HIV positive pati treatment when this number falls belo threshold -currently set by the World Hea [2] . The patients with CD4 cell counts a therefore critical. A number of de that performs at the required lev and/or per-test cost can be large, a per-day can also limit the use of the We present here a finger-press CD4 cell isolation on an autonomo isolating CD4 cells from whole blo sample loading. The very simple, and instrument-free microfluidic pro results and thus meets the crite resource-limited regions where H endemic, and monitoring remains a involves the incubation of whole magnetic beads that specifically bin T-helper cells. This sample is the dically primed microfluidic chip, an times past a magnetic capture isolating the CD4 cells to a location of the blood sample. Critically, the both the loading of the sample, an are generated by deflecting a fluidi the main chamber via a flexible achieved simply by depressing t finger of the operator. Following is they can be semi-quantitatively inspection of the capture chamber.
FROM BLOOD USING FINGER-ACT ORESIS FOR RAPID HIV/AIDS DIAG
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s driven magnetophoretic ous microfluidic chip for ood within 30 seconds of minimum operator-skill ocedure delivers accurate eria for deployment in HIV / AIDS is largely a challenge. The strategy blood with (super)parand to the CD4 epitope of en introduced to a fluind passaged a number of chamber, specifically n removed from the bulk e forces needed to drive nd the fluidic movements ic reservoir connected to membrane. This can be the membrane with the solation of the CD4 cells, enumerated by visual 978-1-4799-3509-3/14/$31.00 ©2014 IEEE
SYSTEM DESIGN
The architecture of the chip display fluidic reservoir (P1) at the base of the ch directly to the separation channel, a seconda is at the top of the separation channel and port is directly below P2. Midway down channel is the CD4 capture locus. On the the capture locus is a vent to allow any ov during the cell separation process (Fig. 2) .
Figure 2: Finger-press actuated magne isolation chip. i) 3D rendering of chip. ii) with the microfluidic features shown using Schematic showing features of interest. D when P1 is depressed or released is indicat Green arrows respectively.
Microchannels (40 μm deep) are fabr [4] and adhered to a glass base. A perm placed perpendicular to the pneumatically liquid (Fig. 2 iii) , and the chamber is fill buffer.
For biosafety reasons, we cannot han blood in our lab. Therefore finger-prick deri from healthy donors was first depleted of na It is then spiked with defined concentrations stained CD4-positive HL60 cells at me concentrations between 10 and 1000 incubated for 3 min with paramagnetic bead CD4 epitope.
SYSTEM OPERATION
To load the chip, the pneumatic cham depressed to reduce the internal volume of sample is applied to the loading inlet and (Fig. 3 i-ii) Fig. 3 iii-iv) . The compensates any shortfall in liquid volume, insuring remains fully primed. The vast magnetically tagged cells follows t P1; only the magnetically tagged, deflected to the base of the flow (Fig. 4) . In order to sequester rem capture chamber, P1 is again pres back towards P2 (Fig. 3 v-vi) . By r commences. By repeating these step pass actuation will complete in ap Quantification of recovered cell fluorescence and bright-field micro chip is amenable to detection using UV-fluorescence detector. 
METHODOLOGY
Chip manufacture
The microfluidic chips used in from polydimethylsiloxane (PDM mixed at a ratio of 10:1 base procedures for making a master a rotating magnet in the PDMS have elsewhere [4] [5] . Loading holes an the PDMS at appropriate locations that the chamber always t background of nonthe laminar flow towards , CD4-positive cells are w-free capture structure maining CD4 cells to the ssed to drive the sample releasing P1 the cycle reps a second time, a dualpproximately 30 seconds. ls was carried out by scopy (Figs. 4-5) , but the g a handheld LED-based tophoresis chip to isolate les) from whole blood. n with Blue (towards P2) n this paper were formed MS; Dow Corning, MI) and curing agent. The and for securing the cobeen described in detail nd vents were defined in s using a dot punch. The PDMS slab containing the microfluidic fea on a 25 × 60 mm glass coverslip and allo 1 min. Finally, the glass / PDMS chip wa PMMA base. To prime the microchannel the chip was placed under vacuum for following which a large drop of priming bu buffered saline [PBS] pH 7.4, 0.1% w/v albumin [BSA], 1 mM EDTA) was immed the surface of the PDMS, covering both th the loading chamber, and the vent. Degas primed the channels. Magnets used we cylindrical magnets, with a diameter of 3 m of 6 mm (Supermagnete, Germany). Magne the molded cavities before the samples we chip.
Blood Processing and Cell Culture
Blood was extracted directly from he finger prick using 1.5 mm sterile lancets ( NJ, USA). To prevent coagulation of th 60 mM EDTA solution was immediatel sample to result in a final concentration of the whole blood. Blood was isolated and directly before experimental use. Native depleted using the T4 Quant Kit (Life Te USA) according to manufacturer's instructio HL60 cells (DSMZ, Braunschweig, cultured in 75 cm 2 flasks in RPMI 1640 m un-inactivated fetal bovine serum, 100 U and 100 μg mL -1 streptomycin. Cultures we 37 °C with 5% CO 2 . Where indicat fluorescently stained with NucBlue Live Technologies) according to the manufacture Experimental samples composed of bl HL60 were treated with Dynabeads CD4 (Life Technologies). Incubations were carri Eppendorf tube, and final incubation volu per sample, composed of 140 μL incubation 7.4, 0.1% w/v BSA, 1 mM EDTA), 50 μ sample, and 10 μL Dynabead CD4. performed at room temperature with rotatio of sample was introduced to the chip as desc
RESULTS
Following a dual-pass actuation of spiked with 4 concentrations of HL concentrations as low as 10 cells μl -1 in w detected. Furthermore, in the medically rel range of 10-1000 CD4 cells μl -1 of whole b showed a linear fluorescent signal output c the concentration of cells. Over this range, Pearson correlation coefficient (RSQ) wa 0.97 (Fig. 5-i) . This suggests that the CD4 patient blood over diagnostic ranges lie wit range of the chip performance -indicating can lead to high predictability of CD4 cou data-point. f the space occupied with the free image analysis milar correlation to HL60 (Fig. 5-ii) . This suggests an be carried out using In spite of the promising results using are the quantification of the data, a future ana may be more accurate using fluorescenc dark-field background. In this case, to keep at a minimum, specific staining using exp based fluorescence markers should be avoid the chip will exclusively isolate CD4 cell capture, when run under non-spiked nati rom Fig. 4. i 
DISCUSSION AND CONCL
To enable rapid, cheap and based on CD4 cell count in a finge blood, we have developed an auton capable of delivering a semi-quant infection. Critically, this chip runs for flow control; and if deployed, w only a bright-field light source wi camera similar to that on mid-ra readout. Compared to the complex on the market for PoC HIV d presented here would be notably without a fully quantitative result cases, a medical practitioner on site patient falls into a "treat" or "no distribution of ART pharmaceuti simplicity of the presented devic nature of the data generated would b
